Lung squamous cell carcinoma (LUSC) is basal-like subtype of lung cancer with limited treatment options. While prior studies have identified tumor-propagating cell states in squamous tumors, the broader landscape of intra-tumoral heterogeneity within LUSC remains poorly understood. Here, we employ Sox2-driven mouse models, organoid cultures, and single-cell transcriptomic analyses to uncover previously unrecognized levels of cell fate diversity within LUSC. Specifically, we identify a KRT13(+) hillock-like population of slower-dividing tumor cells characterized by immunomodulatory gene expression signatures. The tumor hillock-like state is conserved across multiple animal models and is present in the majority of human LUSCs as well as head and neck and esophageal squamous tumors. Our findings shed light on the cellular origins of lung hillock-like states: normal club cells give rise to tumors with luminal hillock-like populations, while basal-like tumor-propagating cells transition into basal hillock-like states, resembling homeostatic cellular responses to lung injury. Mechanistically, we identify KLF4 as a key transcriptional regulator of the hillock-like state, both necessary and sufficient to induce KRT13 expression. Together, these results provide new molecular insights into cell fate plasticity that underlies intra-tumoral heterogeneity in LUSC, offering potential avenues for new therapeutic strategies.
KLF4 promotes a KRT13+ hillock-like state in squamous lung cancer.
KLF4 促进鳞状肺癌中 KRT13+ 小丘样状态的形成
阅读:5
作者:Izzo Luke T, Reyes Tony, Meesala Srijan, Ireland Abbie S, Yang Steven, Sunil Hari Shankar, Cheng Xiao Chun, Tserentsoodol Nomi, Hawgood Sarah B, Patz Edward F Jr, Witt Benjamin L, Tyson Darren R, O'Donnell Kathryn A, Oliver Trudy G
| 期刊: | bioRxiv | 影响因子: | 0.000 |
| 时间: | 2025 | 起止号: | 2025 Mar 13 |
| doi: | 10.1101/2025.03.10.641898 | 研究方向: | 肿瘤 |
| 疾病类型: | 肺癌 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
